104 lots of 33 products were immobilized for patients with high blood pressure.
The Directorate General of Medicines, Supplies and Drugs (Digemid), of the Ministry of Health (Minsa), ordered the withdrawal of 33 products containing valsartan (active ingredient used for arterial hypertension) in response to alerts issued by the European Medicines (EMA) and the Spanish Agency for Medicines and Health Products (AEMPS), which warned of having found a probably carcinogenic impurity.

For more information go to https://www.gob.pe/institucion/minsa/noticias/15464-digemid-dispone-el-retiro-de-productos-con-valsartan-tras-alerta-sobre-posible-impureza-cancerigena